Thermo Fisher Scientific GIBCO CTS LV-MAX Lentiviral Production System

Monday, 13 May, 2019 | Supplied by: Thermo Fisher Scientific


The GIBCO CTS LV-MAX Lentiviral Production System, from Thermo Fisher Scientific, is a complete lentivirus production solution designed to produce high-titre lentiviral vectors greater than 1 x 108 TU/mL (unconcentrated). It is an optimised LV vector production system in suspension culture designed to meet USP <1043> standards.

The system provides a smooth transition from discovery through clinical and commercial manufacturing. It is designed to reduce the cost of viral production, simplify researchers’ workflow, utilise regulatory compliant reagents and provide a clear path towards commercialisation. The cGMP-banked HEK293 cell line for LV production facilitates large-scale production.

Online: thermofisher.com
Phone: 1300 735 292
Related Products

Bio-Rad Laboratories anti-idiotypic antibodies and Human IgM-FcSpyCatcher reagent

Bio-Rad Laboratories has extended its range of recombinant monoclonal anti-idiotypic antibodies...

ProSci Incorporated apoptosis antibodies

ProSci Incorporated provides an extensive catalogue of apoptotic antibodies including death...

TdB Labs polysaccharides

TdB Labs' polysaccharide portfolio consists of both fluorescent and non-fluorescent...


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd